Health Law Update, published by Baker & Hostetler LLP, focuses on legal developments and regulatory issues in the healthcare sector. The blog covers topics such as FDA regulations and guidance, drug and biological product approvals, medical device cybersecurity, pharmaceutical compounding laws, and litigation related to healthcare products and services. It also addresses emerging issues like the use of artificial intelligence in drug development and legal challenges to healthcare policies and approvals. The content is aimed at providing updates on compliance, enforcement, and policy changes affecting healthcare providers, manufacturers, and related stakeholders.
YEAR-END LEGISLATIVE OVERDRIVE
This week is crunch time on a host of legislative priorities, and various health-related provisions hang in the balance.
Lawmakers and staff worked all weekend negotiating on legislation to fund the government beyond next Friday’s deadline, when…
HEALTH PROVISIONS FACE UNCERTAINTY AS CONGRESS RETURNS FOR BUSY DECEMBER
Congress returns to Washington this week after the Thanksgiving holiday with only 18 days before the government runs out of money – and that’s not even the most important issue…
FDA NOMINATION HEARING DRIVES THE WEEK IN HEALTH POLICY
President Trump’s nominee to lead the Food and Drug Administration, Dr. Stephen Hahn, will appear Wednesday before the Senate Health, Education, Labor and Pensions Committee for a hearing on his nomination.…
COMPREHENSIVE DRUG BILL STALLS WHILE HOUSE PUSHES SMALLER MEASURES
House Democrats are planning to take up more narrow bills addressing prescription drug costs while their broad legislation is delayed as the Congressional Budget Office (CBO) works on estimating its budgetary…
DEMOCRATS PRESS FOR PRE-THANKSGIVING VOTE ON DRUG PRICING BILL
The House Ways and Means Committee last week approved an amended version of legislation that would overhaul how Medicare and private insurers reimburse for prescription drugs, setting up what Democrats hope…
PELOSI INTRODUCES DRUG PRICING BILL WHILE TRUMP PUSHES SENATE VERSION
House Democrats introduced legislation last week to lower prescription drug prices – including allowing Medicare to negotiate prices with manufacturers – and set an aggressive timeline to approve the bill…
PELOSI DRUG PRICE PLAN EXPECTED THIS WEEK
House Speaker Nancy Pelosi, D-Calif., is expected to release her long-awaited plan this week to address prescription drug costs, according to congressional staff.
A draft summary of the proposal that circulated last…
UPDATE ON DRUG PRICING LEGISLATION AS CONGRESS RECONVENES
Congress reconvenes this week after a monthlong summer recess and begins what likely will be a final push toward overhauling prescription drug prices, but lack of consensus on the underlying policy and…
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
MAJOR HEALTH POLICY UNLIKELY IN POTENTIAL DEBT-SPENDING DEAL
As House Speaker Nancy Pelosi, D-Calif., and the Trump administration edge…
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
SENATORS RACE TO FINISH DRUG PRICING BILL AS TRUMP PLANS STALL
With only 15 legislative days before a scheduled monthlong recess, Senate…
